Cosmos Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.63 M
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.50 Cr
- Revenue Growth 9.79%
- Profit Growth 102.42%
- Ebitda 37.33%
- Net Worth 6.79%
- Total Assets 2.53%
About Cosmos Biosciences
Cosmos Biosciences Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 April 2008 and has a history of 16 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.63 M.
The company has closed loans amounting to ₹7.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Munish Gupta, Ashish Gupta, and Niren Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110DL2008PTC177330
- Company No.
177330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cosmos Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munish Gupta  | Director | 02-May-2011 | Current |
| Ashish Gupta | Director | 02-May-2011 | Current |
| Niren Gupta | Director | 10-Mar-2021 | Current |
Financial Performance of Cosmos Biosciences.
Cosmos Biosciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.79% increase. The company also saw a substantial improvement in profitability, with a 102.42% increase in profit. The company's net worth moved up by a moderate rise of 6.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmos Biosciences?
In 2020, Cosmos Biosciences had a promoter holding of 10.39% and a public holding of 89.61%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sdb Steel And Pipe Private LimitedNiren Gupta is a mutual person
Energy Oilfield Tools Private LimitedMunish Gupta and Niren Gupta are mutual person
Allied Hitech Industries Private LimitedMunish Gupta, Ashish Gupta and 1 more are mutual person
Allied Hti Private LimitedMunish Gupta, Ashish Gupta and 1 more are mutual person
- Allied Krishna Processing Industries Private Limited
Munish Gupta and Niren Gupta are mutual person
- Eot Couplings And Connections Private Limited
Munish Gupta and Niren Gupta are mutual person
Charges (Loans)
₹0
₹7.50 Cr
Charges Breakdown by Lending Institutions
- Aditya Birla Finance Limited : 7.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2013 | Aditya Birla Finance Limited | ₹7.50 Cr | Satisfied |
How Many Employees Work at Cosmos Biosciences?
Unlock and access historical data on people associated with Cosmos Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmos Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmos Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
